The Auresine technology was promoted by Izabela Sabała during 3rd AMR Conference in Berlin. The ARM Conference aimed at bringing together SMEs, start-ups, big pharma, academia and investors to discuss strategies of transferring newly developed antimicrobials to the market. Our latest results were shown on the poster “Bacteriolytic enzyme Auresine – a new weapon against staphylococcus“. The presented results interested many potential collaborators and investors.
Latest News
-
We are hiring !!!
19/11/2020
-
BioConvention Digital – 8-12 June, 2020
21/05/2020
-
February 2020 – Portugal & Germany
23/02/2020
-
Merry Christmas
23/12/2019
-
Medica 2019 – Come and see us at Stand no. 16A21, Hall 16
14/11/2019
-
Auresine team attended III Wound Management Forum, 10-12 October 2019, Karpacz, Poland
10/10/2019
-
The Great Wall Symposium, 25-27 September 2019, Paris, France
25/09/2019
-
Auresine team attended Workshop on data collection and structure solving in macromolecular X-ray diffraction, 12-16.07.2019 – Cracow, Poland
12/07/2019